2^nd World Congress on
Kidney and Renal Biomarkers

Dr.Youssef El Gammal- Head of Urology, nephrology and Dialysis Departments in Ajman Speciality General Hospital - UAE. He was born in TANTA, Egypt and completed his higher education in: Tanta university, faculty of medicine , Royal college of surgeon of LONDON, EDENBERAH - UK , M.D. NIXON university USA. Dr.Youssef El Gammal was brilliant in his educational career. He contributed a lot to success in his professional life. He worked as: medical inter , SHO, Specialist ,consultant , chief doctor ,General manager and supervisor of the departments in Tanta uni. and in Tullamore General hospital - DEBLIN - IRELAND, ROYAL hospital - Sharjah and MMC - MIDICLINIC middle east and Ajman Speciality General hospital- UAE . Dr.Youssef El Gammal received many awards for his great contribution in his field of activities and researchers and also published paper in XX11nd congress of the EDTA - ERA about CAPD. He achieved many things as Urologist and Nephrologist.

Urology, Nephrology and Dialysis Departments

.

Bioinformatics, Molecular Biology, Immunology, Bioprocessing, Drug Discovery & Marketing.

Experienced Professor with a demonstrated history of working in the medical practice. Skilled in Epidemiology, Lecturing, Public Speaking, Curriculum Development, and Therapeutics. Strong education professional with a Nefrologia Emodialisi focused in Nefrologia Emodialisi from Ospedale Il Policlinico Roma. and Ospedale Ca 'Granda, Milano, also in General Hospital of Athens.

Diabetic Kidney Diseases, Kidney Transplantation, Hemodialysis.

Prof. Petra Reinke is Nephrologist / Clinical Scientist - scientific topics: transplantation medicine, development of new diagnostic and therapeutic approaches in transplantation. She is Project coordinator for the EU founded FP7 consortium “BIO-DrIM”, was Steering committee member / work-package leader of the EU founded FP7 consortium “ONE- Study”, Steering committee member / work-package leader of the EU founded FP6 consortium “RISET”, Co-PI for a project founded by the Immune Tolerance Network, Co-Investigator ROTF grant. She is Head of the “Kidney Transplant Outpatient Clinic”; Head of research area “immune system”, Head of the GMP-Facility, Steering Committee Member of the Berlin-Brandenburg Center for Regenerative Therapies, of the DFG-sponsored Berlin-Brandenburg School for Regenerative Therapies, of the Berlin Institute of Health (BIH) Stem Cell Center. She published more than 300 articles.

Transplantation medicine

Thomas Ryzlewicz has completed his PhD from Free University in Berlin (West). He started dialysis treatment in 1974. In between 2 years in the Physiologic Institute (Berlin-West, theme acid-base status). In1978, he published two papers in Kidney International (co-working with H Hampl) concerning the cardio-vascular behavior during dialysis monitored by left-heart catheter. In 1978, he worked on the development of a rough protoype for bicarbonate dialysis in order to study the amount of acidification. In 1985, he was a Consultant at the Nephrologic Clinic in Regensburg (Bavaria, Germany). He was a Senior Consultant in 1992 (dialysis centre in Ebersberg, near Munich, Germany). He is responsible for handling of many prototypes of dialysis supply systems, e.g., prototypes of hemofiltration (1978) and of the real (2-step) online-hemofiltration (1983-85). He worked on the development of an own bloodline with minimal contact between blood & air in order to reduce the sheer-stress in single fibre capillary (big EPO dosage reduction, product “Oxyless-Line”) which obtained EU patent, US patent, PEMA audit from London, and was published by Ian Macdougal (King’s College, London)

Clinical Medical Education, Renal Osteodystrophy, Secondary Dialysis, Kidney Transplantation

Donald Silverberg Graduated from Medical School University of Manitoba in 1962. He did his Residency in Internal Medicine and Nephrology at the Mayo Clinic Rochester Minnesota in 1962-1966 and Residency in Nephrology, University of Lund, Sweden in 1966-1967. He worked as Nephrologist University Hospital, Edmonton Canada during l968-1976. Has been living in Israel and practicing nephrology since 1976 in Tel Hashomer and Beilinson and Tel Aviv Medical Center. National Director of Hypertension Control Division, Kupat Holim Sick Fund 1978-1986 (Organizing the detection and treatment of hypertension for the Israeli population)

zebrafish to study kidney development and regeneration.

I am an Egyptian physician, Cairo University (M.D., 1994),Master in Nephrology and renal dialysis with training in Lyon – France and PhD clinically attached in Kidney transplantation from Pisa University, Italy. I also published in reputed journals. experience in nephrology, renal replacement therapies and transplantation was acquired through direct contact with excellent staff of university institutions, hospitals and dialysis centers in Egypt, France, Italy, Kuwait and Saudi Arabia

Master in Nephrology and renal dialysis

Lavinia-Oltita Bratescu graduated from University of Medicine and Pharmacy from Timisoara, in Romania (on 2000). She completed her studies with specialization in Nephrology, in 2006. From 2007, she has worked as a neprologist in Sf Pantelimon International Healthcare Systems Nephrology and Dialysis Medical Center, in Bucharest. From 2012, she has been a chief physician of the same medical center. She completed her PhD in November 2013. She has participated in national and international nephrology conferences as a speaker and as poster presenter.

Nephrology and Dialysis

Josep M. Campistol is currently the General Director of the Hospital Clinic of Barcelona, Spain, and former Medical Director of the same hospital as well as Director of the Clinical Institute of Nephrology and Urology (ICNU). He is also Professor of Medicine at the Nephrology Department of the University of Barcelona. He received his medical degree from the University of Barcelona in 1983, and completed his residency in internal medicine and, subsequently, his fellowship in renal medicine at the Hospital Clinic of the same institution. Following his training as a fellow in renal medicine at the University of Barcelona, Prof. Campistol continued his clinical work in renal transplantation within the Renal Transplant Unit at the Hospital Clinic. During this period, he also developed research interests into the pathogenesis of dialysis-related amyloidosis, and undertook a visiting Fulbright Scholarship at Boston University School of Medicine in Boston, MA, USA (1991– 1992). His doctoral thesis (1990) was based on the ‘Pathogenesis of dialysis-amyloidosis and the role of lymphocytes on beta-2-microglobulin synthesis and dialysis membranes’. Prof. Campistol has published more than 700 experimental and clinical papers in international peer-reviewed journals. He is a member of many international transplant societies, on the editorial board of a number of major international transplant journals and a principal investigator in numerous clinical studies. His current research interests include the use of new immunosuppressive regimens in renal transplantation, mechanisms of allograft fibrosis and renal regenerative medicine.

use of new immunosuppressive regimens in renal transplantation, mechanisms of allograft fibrosis and renal regenerative medicine.

Josep M. Campistol is currently the General Director of the Hospital Clinic of Barcelona, Spain, and former Medical Director of the same hospital as well as Director of the Clinical Institute of Nephrology and Urology (ICNU). He is also Professor of Medicine at the Nephrology Department of the University of Barcelona. He received his medical degree from the University of Barcelona in 1983, and completed his residency in internal medicine and, subsequently, his fellowship in renal medicine at the Hospital Clinic of the same institution. Following his training as a fellow in renal medicine at the University of Barcelona, Prof. Campistol continued his clinical work in renal transplantation within the Renal Transplant Unit at the Hospital Clinic. During this period, he also developed research interests into the pathogenesis of dialysis-related amyloidosis, and undertook a visiting Fulbright Scholarship at Boston University School of Medicine in Boston, MA, USA (1991– 1992). His doctoral thesis (1990) was based on the ‘Pathogenesis of dialysis-amyloidosis and the role of lymphocytes on beta-2-microglobulin synthesis and dialysis membranes’. Prof. Campistol has published more than 700 experimental and clinical papers in international peer-reviewed journals. He is a member of many international transplant societies, on the editorial board of a number of major international transplant journals and a principal investigator in numerous clinical studies. His current research interests include the use of new immunosuppressive regimens in renal transplantation, mechanisms of allograft fibrosis and renal regenerative medicine

Renal Transplant